Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress

Following our identification of PTEN‐induced putative kinase 1 (PINK1) gene mutations in PARK6‐linked Parkinson's disease (PD), we have recently reported that PINK1 protein localizes to Lewy bodies (LBs) in PD brains. We have used a cellular model system of LBs, namely induction of aggresomes, to determine how a mitochondrial protein, such as PINK1, can localize to aggregates. Using specific polyclonal antibodies, we firstly demonstrated that human PINK1 was cleaved and localized to mitochondria. We demonstrated that, on proteasome inhibition with MG‐132, PINK1 and other mitochondrial proteins localized to aggresomes. Ultrastructural studies revealed that the mechanism was linked to the recruitment of intact mitochondria to the aggresome. Fractionation studies of lysates showed that PINK1 cleavage was enhanced by proteasomal stress in vitro and correlated with increased expression of the processed PINK1 protein in PD brain. These observations provide valuable insights into the mechanisms of LB formation in PD that should lead to a better understanding of PD pathogenesis.

[1]  E. Sztul,et al.  Characterization and Dynamics of Aggresome Formation by a Cytosolic Gfp-Chimera✪ , 1999, The Journal of cell biology.

[2]  D. Perl,et al.  Aggresome‐related biogenesis of Lewy bodies , 2002, The European journal of neuroscience.

[3]  M. Yokochi,et al.  An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism , 2004, Acta Neuropathologica.

[4]  M. Cookson,et al.  Mitochondria and Dopamine New Insights into Recessive Parkinsonism , 2004, Neuron.

[5]  D. Perl,et al.  Lewy-body formation is an aggresome-related process: a hypothesis , 2004, The Lancet Neurology.

[6]  R. Kopito,et al.  Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.

[7]  H. Lehrach,et al.  Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. , 2001, Molecular biology of the cell.

[8]  J. Holton,et al.  PINK1 protein in normal human brain and Parkinson's disease. , 2006, Brain : a journal of neurology.

[9]  H. Gertz,et al.  Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease , 1994, Brain Research.

[10]  M. Sakaguchi,et al.  BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential. , 2003, Cancer Letters.

[11]  R. Jensen,et al.  Protein import into and across the mitochondrial inner membrane: role of the TIM23 and TIM22 translocons. , 2002, Biochimica et biophysica acta.

[12]  Takeshi Iwatsubo,et al.  Aggresomes Formed by α-Synuclein and Synphilin-1 Are Cytoprotective* , 2004, Journal of Biological Chemistry.

[13]  W. Hill,et al.  Contribution of somal Lewy bodies to neuronal death , 1997, Brain Research.

[14]  I. Arnold,et al.  Characterization of Peptides Released from Mitochondria , 2005, Journal of Biological Chemistry.

[15]  David W. Miller,et al.  Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[17]  K. Tokuyasu.  Application of cryoultramicrotomy to immunocytochemistry , 1986, Journal of microscopy.

[18]  M. Gonzalo Claros,et al.  MitoProt, a Macintosh application for studying mitochondrial proteins , 1995, Comput. Appl. Biosci..

[19]  E. Valente,et al.  Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. , 2005, Human molecular genetics.

[20]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[21]  H. Shio,et al.  Polypeptide and phospholipid composition of the membrane of rat liver peroxisomes: comparison with endoplasmic reticulum and mitochondrial membranes , 1982, The Journal of cell biology.

[22]  Kay Hofmann,et al.  Tmbase-A database of membrane spanning protein segments , 1993 .

[23]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[24]  N. Pfanner,et al.  How mitochondria import hydrophilic and hydrophobic proteins. , 2002, Trends in cell biology.

[25]  A. Bentivoglio,et al.  PINK1 mutations are associated with sporadic early‐onset parkinsonism , 2004, Annals of neurology.

[26]  I. Kanazawa,et al.  Cu/Zn superoxide dismutase-like immunoreactivity is present in Lewy bodies from Parkinson disease: a light and electron microscopic immunocytochemical study , 2004, Acta Neuropathologica.

[27]  Nobutaka Hattori,et al.  Novel PINK1 mutations in early‐onset parkinsonism , 2004, Annals of neurology.

[28]  G. von Heijne,et al.  Domain structure of mitochondrial and chloroplast targeting peptides. , 1989, European journal of biochemistry.

[29]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[30]  Pietro Cortelli,et al.  Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism , 2004, Annals of neurology.

[31]  M. Beal.  Energetics in the pathogenesis of neurodegenerative diseases , 2000, Trends in Neurosciences.

[32]  P. S. St George-Hyslop,et al.  Wild-type PINK1 Prevents Basal and Induced Neuronal Apoptosis, a Protective Effect Abrogated by Parkinson Disease-related Mutations* , 2005, Journal of Biological Chemistry.

[33]  D. Perl,et al.  Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease , 2004, Annals of neurology.

[34]  G. Scott,et al.  UCH‐L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease , 2004, Journal of neurochemistry.

[35]  Richard Mayeux,et al.  Epidemiology of neurodegeneration. , 2003, Annual review of neuroscience.

[36]  W. Parker,et al.  Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies , 2004, Journal of neurochemistry.

[37]  J. Hendrick,et al.  Survey of amino-terminal proteolytic cleavage sites in mitochondrial precursor proteins: leader peptides cleaved by two matrix proteases share a three-amino acid motif. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  N. Wood,et al.  Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. , 2003, Human molecular genetics.

[39]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[40]  Todd B. Sherer,et al.  An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.

[41]  L. Forno,et al.  Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.

[42]  C. Haass,et al.  How does parkin ligate ubiquitin to Parkinson's disease? , 2004, EMBO reports.

[43]  W. Neupert,et al.  Insertion into the mitochondrial inner membrane of a polytopic protein, the nuclear‐encoded Oxa1p , 1997, The EMBO journal.

[44]  Barry Halliwell,et al.  Failure of the ubiquitin–proteasome system in Parkinson's disease , 2001, Nature Reviews Neuroscience.

[45]  Takeshi Iwatsubo,et al.  Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. , 2004, The Journal of biological chemistry.